Growth Metrics

ClearPoint Neuro (CLPT) Notes Payables (2011 - 2024)

ClearPoint Neuro recorded quarterly Notes Payables of $10.0 million in Q2 2024, little changed quarter-over-quarter from $10.0 million in Q1 2024.

ClearPoint Neuro's Notes Payables history runs 9 years deep, the most recent figure standing at $10.0 million for Q2 2024.

  • In Q2 2024, Notes Payables changed N/A year-over-year to $10.0 million; the TTM figure through Jun 2024 stood at $10.0 million (changed N/A YoY), while the FY2017 annual figure was $1.8 million, down 11.44% from the prior year.
  • Notes Payables came in at $10.0 million for Q2 2024 at ClearPoint Neuro, roughly flat from $10.0 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $10.0 million in Q2 2024 to a low of $10.0 million in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 ClearPoint Neuro 375.84 Mn 340.24 Mn 7.76 Mn

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 9.98 Mn
Mar 31, 2024 9.96 Mn
Jun 30, 2018 2.03 Mn
Mar 31, 2018 1.94 Mn
Dec 31, 2017 1.80 Mn
Dec 31, 2016 2.03 Mn
Sep 30, 2016 1.25 Mn
Jun 30, 2016 3.60 Mn
Mar 31, 2016 1.09 Mn
Sep 30, 2015 933,994.00
Jun 30, 2015 4.68 Mn
Mar 31, 2015 4.56 Mn
Dec 31, 2014 754,328.00
Mar 31, 2014 3.31 Mn
Dec 31, 2013 4.34 Mn
Sep 30, 2013 217,560.00
Jun 30, 2013 3.78 Mn
Mar 31, 2013 202,886.00
Dec 31, 2012 2.00 Mn
Sep 30, 2012 191,023.00
Jun 30, 2012 192,120.00
Dec 31, 2011 3.95 Mn